The Role of Multidimensional Prognostic Index to Identify Hospitalized Older Adults with COVID-19 Who Can Benefit from Remdesivir Treatment: An Observational, Prospective, Multicenter Study
-
Published:2023-06-13
Issue:7
Volume:40
Page:643-651
-
ISSN:1170-229X
-
Container-title:Drugs & Aging
-
language:en
-
Short-container-title:Drugs Aging
Author:
Custodero Carlo, Veronese NicolaORCID, Topinkova Eva, Michalkova Helena, Polidori Maria Cristina, Cella Alberto, Cruz-Jentoft Alfonso J., von Arnim Christine A. F., Azzini Margherita, Gruner Heidi, Castagna Alberto, Cenderello Giovanni, Custureri Romina, Zieschang Tania, Padovani Alessandro, Sanchez-Garcia Elisabet, Pilotto Alberto, Barbagallo Mario, Dini Simone, Diesner Naima Madlen, Fernandes Marilia, Gandolfo Federica, Garaboldi Sara, Musacchio Clarissa, Pilotto Andrea, Pickert Lena, Podestà Silvia, Ruotolo Giovanni, Sciolè Katiuscia, Schlotmann Julia,
Funder
Università degli Studi di Palermo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference37 articles.
1. National Center for Health Statistics. Provisional COVID-19 deaths by sex and age. 2022. https://data.cdc.gov/d/9bhg-hcku. Cited 2 Dec 2022. 2. Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—a possible reference for coronavirus disease-19 treatment option. J Med Virol. 2020;92(6):556–63. 3. Kokic G, Hillen HS, Tegunov D, Dienemann C, Seitz F, Schmitzova J, et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat Commun. 2021;12(1):1–7. 4. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of covid-19—final report. N Engl J Med. 2020;383(19):1813–26. 5. Consortium WHOST, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, et al. Repurposed antiviral drugs for covid-19—interim WHO solidarity trial results. N Engl J Med. 2021;384(6):497–511.
|
|